Cargando…

Correction: Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Detalles Bibliográficos
Autores principales:	Stocker, H., Perna, L., Weigl, K., Möllers, T., Schöttker, B., Thomsen, H., Holleczek, B., Rujescu, D., Brenner, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758469/ https://www.ncbi.nlm.nih.gov/pubmed/34599279 http://dx.doi.org/10.1038/s41380-021-01311-x

Ejemplares similares

Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
por: Stocker, H., et al.
Publicado: (2020)

Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
por: Stocker, Hannah, et al.
Publicado: (2023)

Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023)

Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia
por: Möllers, T., et al.
Publicado: (2019)

Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease
por: Möllers, Tobias, et al.
Publicado: (2021)

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer’s disease
por: Stocker, Hannah, et al.
Publicado: (2021)

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
por: Stocker, Hannah, et al.
Publicado: (2018)

Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood
por: Möllers, Tobias, et al.
Publicado: (2021)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
por: Nguyen, Thi Ngoc Mai, et al.
Publicado: (2022)

A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
por: Raut, Janhavi R., et al.
Publicado: (2021)

Age-dependent effect of APOE and polygenic component on Alzheimer's disease
por: Bellou, Eftychia, et al.
Publicado: (2020)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk
por: Guan, Zhong, et al.
Publicado: (2019)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
por: Ebenau, Jarith L., et al.
Publicado: (2021)

Frailty is associated with the epigenetic clock but not with telomere length in a German cohort
por: Breitling, Lutz Philipp, et al.
Publicado: (2016)

Amyloid blood biomarker detects Alzheimer's disease
por: Nabers, Andreas, et al.
Publicado: (2018)

Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study
por: Trares, Kira, et al.
Publicado: (2022)

Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic?
por: Brenner, Hermann, et al.
Publicado: (2020)

Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality
por: Zhang, Yan, et al.
Publicado: (2015)

Considering the APOE locus in Alzheimer’s disease polygenic scores in the Health and Retirement Study: a longitudinal panel study
por: Ware, Erin B., et al.
Publicado: (2020)

Polygenic score modifies risk for Alzheimer's disease in APOE ε4 homozygotes at phenotypic extremes
por: Huq, Aamira J., et al.
Publicado: (2021)

Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study
por: Li, Xiangwei, et al.
Publicado: (2022)

Association of longitudinal repeated measurements of frailty index with mortality: Cohort study among community-dwelling older adults
por: Li, Xiangwei, et al.
Publicado: (2022)

Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure
por: Bhardwaj, Megha, et al.
Publicado: (2023)

A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE
por: Altmann, Andre, et al.
Publicado: (2019)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population
por: Riaz, Moeen, et al.
Publicado: (2021)

Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort
por: Perna, Laura, et al.
Publicado: (2016)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults
por: Xicota, Laura, et al.
Publicado: (2022)

DNA methylation signatures in peripheral blood strongly predict all-cause mortality
por: Zhang, Yan, et al.
Publicado: (2017)

Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study
por: Perna, Laura, et al.
Publicado: (2023)

Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer’s disease outside of the APOE region
por: de la Fuente, Javier, et al.
Publicado: (2022)

Methylomic survival predictors, frailty, and mortality
por: Zhang, Yan, et al.
Publicado: (2018)

A polygenic risk score for Alzheimer’s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
por: Sofer, Tamar, et al.
Publicado: (2023)

Apolipoprotein E moderates the association between Non-APOE Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive Function
por: Xu, Yuexuan, et al.
Publicado: (2023)

APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
por: Håglin, Sofia, et al.
Publicado: (2023)

Smoking-associated DNA methylation markers predict lung cancer incidence
por: Zhang, Yan, et al.
Publicado: (2016)

Distribution and Determinants of Vitamin D-Binding Protein, Total, “Non-Bioavailable”, Bioavailable, and Free 25-Hydroxyvitamin D Concentrations among Older Adults
por: Zhu, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3n1ata6004a4u227m2nuhd0fk